HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mozley, P. D. Articles by Kung, H. F. Search for Related Content PubMed PubMed Citation Articles by Mozley, P. D. Articles by Kung, H. F.

Effects of Age on Dopamine Transporters in Healthy Humans

Departments of Radiology and Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

Correspondence: For correspondence or reprints contact: P. David Mozley, MD, 110 Donner Bldg., Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104.

ABSTRACT

^99mTc-TRODAT-1 is a new radiopharmaceutical that selectively binds the dopamine transporters. This study characterized the effects of aging on its regional cerebral distribution in healthy human volunteers. Methods: The sample consisted of 27 men and 28 women with a mean age of 41.1 ± 17.1 y (age range 18.7–73.8 y). Dynamic SPECT scans of the brain were obtained with a standardized acquisition and processing protocol on a triple-head camera. Mean counts per pixel were measured in multiple regions of interest within each basal ganglia. Regression analyses were used to relate the specific uptake values at 3–4 h after administration to age. Both linear and nonlinear models of aging were tested. Results: The relative concentration of radio activity in most subregions of the basal ganglia decreased significantly with age (all P values < 0.0001). Nonlinear models of aging fit the data significantly better than a straight line. The rate of decline was significantly faster in young adults than in older volunteers (P < 0.001). The break-point age at which the rate of change slowed down and became more stable was 36 y old for the whole striatum and ranged from 32 to 44 y old depending on subregion. Conclusion: The effects of aging on central nervous system dopamine transporters do not appear to be linear. Most effects seem to occur during young adulthood before people reach their 40s. The distribution then appears to remain relatively stable until late in life. The findings suggest that the adult life cycle is better characterized as a series of phases than as a continuum.

Key Words: ^99mTc • normal • tomography emission computed

This article has been cited by other articles:

				W. Koch, O. Pogarell, G. Popperl, J. Hornung, C. Hamann, F.-J. Gildehaus, K. Seelos, D. Lewis, A. Favit, and K. Tatsch Extended Studies of the Striatal Uptake of 99mTc-NC100697 in Healthy Volunteers J. Nucl. Med., January 1, 2007; 48(1): 27 - 34. [Abstract] [Full Text] [PDF]

				G. J. E Schmitt, E. M. Meisenzahl, T. Frodl, C. La Fougere, K. Hahn, H- J. Moller, and S. Dresel The striatal dopamine transporter in first-episode, drug-naive schizophrenic patients: evaluation by the new SPECT-ligand[99mTc]TRODAT-1 J Psychopharmacol, September 1, 2005; 19(5): 488 - 493. [Abstract] [PDF]

				A. B. Newberg, J. D. Amsterdam, N. Wintering, K. Ploessl, R. L. Swanson, J. Shults, and A. Alavi 123I-ADAM Binding to Serotonin Transporters in Patients with Major Depression and Healthy Controls: A Preliminary Study J. Nucl. Med., June 1, 2005; 46(6): 973 - 977. [Abstract] [Full Text] [PDF]

				S. A. Gardiner, M. F. Morrison, P. D. Mozley, L. H. Mozley, C. Brensinger, W. Bilker, A. Newberg, and M. Battistini Pilot Study on the Effect of Estrogen Replacement Therapy on Brain Dopamine Transporter Availability in Healthy, Postmenopausal Women Am J Geriatr Psychiatry, December 1, 2004; 12(6): 621 - 630. [Abstract] [Full Text] [PDF]

				Y.-H. Weng, T.-C. Yen, M.-C. Chen, P.-F. Kao, K.-Y. Tzen, R.-S. Chen, S.-P. Wey, G. Ting, and C.-S. Lu Sensitivity and Specificity of 99mTc-TRODAT-1 SPECT Imaging in Differentiating Patients with Idiopathic Parkinson's Disease from Healthy Subjects J. Nucl. Med., March 1, 2004; 45(3): 393 - 401. [Abstract] [Full Text]

				W.-S. Huang, S.-Z. Lin, J.-C. Lin, S.-P. Wey, G. Ting, and R.-S. Liu Evaluation of Early-Stage Parkinson's Disease with 99mTc-TRODAT-1 Imaging J. Nucl. Med., September 1, 2001; 42(9): 1303 - 1308. [Abstract] [Full Text] [PDF]

				F. Fazio and D. Perani Importance of Partial-Volume Correction in Brain PET Studies J. Nucl. Med., November 1, 2000; 41(11): 1849 - 1850. [Full Text] [PDF]